If generating more passive income is one of your New Year's resolutions, you have plenty of options for achieving the goal.

The woman started experiencing the rapid growth one week after getting vaccinated in September 2022 — and it worsened after ...

You don't need a prescription to purchase a test that will tell you whether you're sick with COVID or the flu.

Cancer-focused CytomX Therapeutics Inc. will lay off 40% of its workforce to help extend its cash into second-quarter 2026, ...

From condemning the Jan. 6 Capitol riots to helping fund the President-elect’s impending inauguration, recent years have seen ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

By Tom Loftus Kentucky Lantern Another $50,000 from tobacco giant Altria last month brings money raised to expand the ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

The final four dividend stocks to buy and hold in 2025 are a mixed assortment. The common denominators between these stocks ...

Explore the recent performance of the SCHD ETF's performance in 2024 and what to expect in the next few months and why it may ...